ALKERMES | ALKS - Dividend Yield


ALKERMES reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
AbbVie 2.71 0.38 Jun/2026
Amgen 2.71 0.08 Jun/2026
Bristol-Myers Squibb 4.36 0.23 Jun/2026
Coherus Biosciences 0 0 Mar/2025
Eli Lilly 0.56 0.02 Jun/2026
Gilead Sciences 2.55 0.26 Jun/2026
Heron Therapeutics 0 0 Mar/2025
J&J 2.06 0.1 Jun/2026
Merck 2.62 0.14 Jun/2026
Minerva Neurosciences 0 0 Mar/2025
Nektar Therapeutics 0 0 Mar/2025
Otsuka Holdings 1.3 0.02 Jun/2026
Pfizer 7.08 0.72 Jun/2026
Regeneron Pharmaceuticals 0.58 0.12 Jun/2026